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and ‡Department of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, CaliforniaABSTRACT The mechanisms that control cardiac contractility are complex. Recent work we conducted in vertebrate skeletal
muscle identified a new state of myosin, the super-relaxed state (SRX), which had a very low metabolic rate. To determine
whether this state also exists in cardiac muscle we used quantitative epi-fluorescence to measure single nucleotide turnovers
by myosin in bundles of relaxed permeable rabbit ventricle cells. We measured two turnover times—one compatible with the
normal relaxed state, and onemuch slower which was shown to arise frommyosin heads in the SRX. In both skeletal and cardiac
muscle, the SRX appears to play a similar role in relaxed cells, providing a state with a very low metabolic rate. However, in
active muscle the properties of the SRX differ dramatically. We observed a rapid transition of myosin heads out of the SRX
in active skeletal fibers, whereas the population of the SRX remained constant in active cardiac cells. This property allows
the SRX to play a very different role in cardiac muscle than in skeletal muscle. The SRX could provide a mechanism for
decreasing the metabolic load on the heart, being cardioprotective, particularly in time of stress such as ischemia.INTRODUCTIONUnderstanding the metabolic rate of the myocardium and its
control is an active area of investigation. The work produced
and energy used in a single twitch can vary over a large
range, influenced bymuscle length, protein phosphorylation,
and oxygen availability (for review, see (1)). During times of
stress, ischemia, or hypoxia, the myocardium can rapidly
downregulate output and energy use to very low levels (2).
The major element controlling active force is exerted
through calcium binding to the thin filament. A wide varia-
tion in force is produced by variation in the amount of
calcium released into the cell interior. However, there has
been increasing evidence that force can also be modulated
by the thick filament (for review, see (3)). The structure of
the cardiac thick filament is known to undergo dynamic
changes produced by alterations in protein phosphorylation,
and these changes have been associated with variation in
cardiac output and energy utilization (3–9). Here we investi-
gate what we believe is a new state of cardiac myosin, the
super-relaxed state (SRX), and discuss the potential physio-
logical function and importance of this state.
We have recently used quantitative epi-fluorescence to
measure single nucleotide turnovers in relaxed skeletal
muscle fibers and identified what to our knowledge is
a new relaxed state of myosin in skeletal muscle, the SRX
(10). This state has an ATP turnover rate that is an order-
of-magnitude smaller than that normally observed in chem-
ically skinned skeletal muscle fibers or purified myosin.
Although it has long been recognized that there are multiple,
attached force-generating actomyosin chemomechanicalSubmitted December 8, 2010, and accepted for publication February 14,
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0006-3495/11/04/1969/8 $2.00states in the active cycle, this was, to our knowledge, the first
identification of relaxed states with such widely disparate
kinetic properties and represents a paradigm shift in the
description of relaxed muscle. Myosin heads are still relaxed
in the classical sense; they are detached from actin and not
generating force. However, their ATP turnover can differ
dramatically according to which subpopulation within the
relaxed state that they occupy. Furthermore, resting energy
utilization can be modulated via perturbation of the relative
fractions of the two relaxed states.
This work extends these studies to resting cardiac muscle
cells, as well as to active skeletal and cardiac muscle cells.
We show that there is an SRX in resting cardiac muscle with
properties similar to those seen in resting skeletal fibers.
However, here we extend these studies to active muscle,
and in active muscles, the characteristics of this state differ
between the two types of muscle. We demonstrate that the
properties of the cardiac SRX would allow it to serve as
a modulator of cardiac energy utilization and contractility,
and that in particular it could be involved in decreasing
metabolic rate in both the normally functioning myocar-
dium and during times of hypoxic or other stress.MATERIALS AND METHODS
Fiber preparations and solutions
Rabbit cardiac ventricle muscle was harvested and cut into strips (diameter
~2 mm, length ~6 mm) and attached to sticks under low tension. Then the
cells were chemically skinned as described in the Supporting Material and
stored at 20C. Removal of the membranes allows modulation of the
chemical milieu surrounding a relatively intact myofilament array.
The cardiac muscle strips were manually dissected into small bundles of
cells having a diameter between 40 and 80 mm, and mounted in a simple
flow cell as described in the Supporting Material. Sarcomere lengths varied
from 1.9–2.2 mm. Temperature was 265 1C.doi: 10.1016/j.bpj.2011.02.061
1970 Hooijman et al.Solutions
The basic rigor buffer contained 120 mM KAcetate, 5 mM MgAcetate2,
5 mM EGTA, 2.5 mM K2HPO4, 2.5 mM KH2PO4, and 50 mM 3-(n-mor-
pholino)propanesulfonic acid, pH 6.8, with daily fresh addition of 2 mM
DTT. Nucleotides were added to the stated concentrations.1Basic protocol
The ATPase turnover was measured by means of the replacement of the
fluorescent nucleotides, 20(30)-O-n-methylanthraniloyl-ATP (mantATP),
by nonfluorescent nucleotides or vice versa. The fluorescent-nucleotide
mantATP has a long history as an ATP analog used to measure kinetic rates
in myosin (11–13). In the standard experiment, the mounted cells were first
washed with rigor solution to remove any residual nucleotide from the skin-
ning process. Then, the cells were incubated for several minutes with the
fluorescent nucleotides, mantATP or mantADP, until maximum fluores-
cence was reached (incubation phase). Measurement of tension of bundles
of cardiac cells in 250 mM mantATP or 4 mM ATP showed that the fibers
were relaxed, tension<2% of fully activated (see the Supporting Material).
This shows that the activation of relaxed fibers seen at higher temperatures
has not occurred during the incubation phase (14). The fluorescence of
mant-nucleotides increases when bound to the myosin nucleotide pocket
(11–13). Subsequently, the fluorescent nucleotides were chased by nonflu-
orescent nucleotides (chase phase).
The intensities initially obtained in the incubation phase were used to
normalize the data obtained during the chase phase. Fibers were incubated
for 2 min in the incubation phase before the chase. Between each run, the
cell preparation was washed with rigor buffer several times to remove all
nucleotides before another run. Up to three runs could be done on a single
bundle of cells without deterioration, e.g., <10% change in populations or
time constants. Runs were separated by a rigor wash for at least 6 min to
remove free and bound nucleotides. In the reverse experiment, nonfluores-
cent nucleotides are chased by fluorescent nucleotides. The cells were first
incubated with ATP or ADP and then chased by mantATP or mantADP. The
data were normalized to the level obtained when the cells were incubated in
only mantATP or mantADP in another run on the same bundle.0
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cycling cross-bridges in relaxed muscle
Fluorescence intensity, I, as a function of time, t, was fit using a two-expo-
nential fit of the form
I ¼ 1 P1ð1 exp ðt=T1ÞÞ  P2ð1 exp ðt=T2ÞÞ;
where P1 and P2 are the relative initial fractions in the two states and T1 and
T2 are the time constants for the life of the state. The equation for the fits to
intensity increase was obtained by subtracting the expression on the right-
hand side of the above equation from 1. Fitting was done using a nonlinear
least-squares algorithm in KaleidaGraph Version 3.6 (Synergy Software,
Reading, PA). The fit also defined the 95% confidence limits.
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FIGURE 1 Changes in fluorescence intensity during the chase phase of
the single nucleotide turnover experiments are shown for mantATP chased
by ATP (O), and for ATP chased by mantATP (C). In both experiments the
intensity changes in two phases—a rapid phase with a time constant of
~10–15 s and a slow phase with a time constant of ~140 s. The symmetry
between the two experiments shows that the single nucleotide turnover
measurements are the same for mantATP replacing ATP and for ATP
replacing mantATP. The data were fit with a double-exponential function
(solid lines). Parameters of the fits to the data shown here are provided in
the Supporting Material.Apparatus
Fluorescence images were acquired on a model No. TE2000 microscope
(Nikon, Melville, NY) with a CoolSNAP HQ2 camera (Photometrics,
Tucson, AZ). The average fluorescence intensities within small rectangular
areas, 15–30 mm  20–40 mm, were measured and fiber fluorescence was
determined by subtracting the background intensity from the fiber intensity.
The data were fit to a two-exponential decay or rise, as described in the
Supporting Material. The fit also defined the 95% confidence limits. The
fluorescence images of nucleotides bound to the cells was visualized using
a spinning disk confocal spectrometer (Nikon).Biophysical Journal 100(8) 1969–1976RESULTS
Measuring single nucleotide turnovers
in permeable cardiac cells
We determined the ATP turnover rate in permeable bundles
of rabbit ventricle muscle by observing the fluorescence
intensity of mantATP using quantitative epi-fluorescence
microscopy. MantATP binds to myosin with high affinity,
functioning similarly to ATP (11,13). Small bundles of cells
were observed in a flow cell that allowed nucleotide solu-
tions to be rapidly exchanged (see Fig. S1 and Fig. S2 in
the Supporting Material). Two protocols were used.
In the first protocol, cells were incubated with a relaxing
solution containing 250mMmantATP, and chased by another
relaxing solution containing 4 mM ATP. The fluorescent
intensity of the muscle decreases with time as mant-nucleo-
tide was released and replaced by excess ATP (see Fig. 1).
The fluorescence intensity decayed rapidly during the first
~30 s followed by a slower decay over several minutes.
In the second protocol, cells were incubated with 4 mM
ATP and chased with 250 mMmantATP. Fluorescence inten-
sity increased as mantATP replaced ATP (see Fig. 1). An
important observation from Fig. 1 is that the populations
and time constants of the two fluorescent phases were not
changed when the order of the nucleotides in the incubation
and chase were switched. This shows that the nucleotide
release rates were not significantly influenced by the use
of the mant-labeled nucleotides. The results were also
unchanged when nucleotide concentrations were varied
(see the Supporting Material).
Cardiac Myosin with a Low Metabolic Rate 1971The fluorescence data could be fit by a sum of two expo-
nentials, one with a short time constant, ~12–25 s, and
a second with a time constant that is much longer, ~140 s
(see Table 1). The fast component represented ~65% of
the total muscle fluorescence. This component is composed
of multiple processes. The diffusion of free nucleotides out
of the muscle bundle of the diameters used here occurs in
~10–15 s (15). The release of nonspecifically bound nucle-
otides is, presumably, also fast. The release of nucleotides
by normally relaxed myosin heads occurs with a time
constant of ~27 s (16), All of these processes are occurring
together and are not resolvable by the present protocol;
however, they contribute to the complexity of the decay,
as discussed in the paragraph below. The slow component
represented ~28% of total muscle fluorescence.
A closer inspection of the fit to the data shows that the
processes involve more than two exponential components.
A fit to the data of Fig. 5 B involving three exponential
processes produced c-squared values that were little
changed. These fits produced one rapid time constant,
~20 s, which accounted for one-half the decay. Thus, the
rapid component was little changed. It produced two slow
components, one with a time constant, 50–100 s and one
with a longer time constant of ~400 s. Similar fits to other
data produced similar results. It is clear that the release of
nucleotides is more complex than can be explained by
a two-exponential fit. However the basic conclusion, that
a fraction of the nucleotides is released quickly, largely
over by 30 s, while a second fraction is released more
slowly, requiring several minutes is unchanged. Thus, we
have chosen to fit the data with a two-exponential decay.Demonstration that the slow nucleotide turnover
arises from nucleotides released by myosin
Below we describe experiments that argue that the fluores-
cent component with a long time constant arises from the
slow release of nucleotides by myosin heads in the SRX.
These include the demonstration thatTABLE 1 Parameters for the two-exponential fit to the data for car
Incubation Chase N P1
mantATP ATP 64 0.665 0
ATP mantATP 9 0.635 0
mantADP ADP 15 0.835 0
ADP* mantATP 17 0.925 0
mantATP þATPy ATP 8 0.515 0
mantATP ADP 17 0.745 0
mantATP ATP/Ca 22 0.645 0
First two columns give the nucleotides in the initial incubation and the chase sol
are the magnitudes and T1 and T2 are the time constants for the first and second p
and Methods). Errors are standard errors of the mean.
*Similar results were obtained in ADP or in rigor (in the absence of nucleotides),
are included in this analysis.
yThe data were normalized to the cell fluorescence in the absence of competitio1. The slow component is not seen if the muscle is not
relaxed during the incubation.
2. Competition by ATP decreases its magnitude.
3. The magnitude of the specifically bound nucleotides is
similar to the concentration of myosin heads.
4. The fluorescence of nucleotides bound to the muscle
during the chase is found mainly in the myosin-contain-
ing A-bands of the sarcomere.
The slow release of nucleotides was not observed when
the muscle was not relaxed in the initial incubation. When
a muscle was incubated in ADP, the myosinADP head
attached to the actin filament forming cross-bridges that
are strongly bound to actin (17). Thus incubating the cells
with mantADP and chasing with ADP, allowed the determi-
nation of nucleotide turnover rate in a nonrelaxed state (see
Fig. 2). The fraction of fluorescence decay with a slow time
constant was much smaller, 0.09, than seen when the muscle
was relaxed in both incubation and chase phases. A similar
control experiment was done with the inverse experiment
with the same result (see Table 1).
The specificity of mantATP bound in the cell bundle was
determined by competition with ATP. Cells were incubated
with a relaxing solution containing 250 mM mantATP plus
varying concentrations of ATP. The measured fluorescence
intensity as a function of added [ATP] is shown in Fig. 3
and fit by an equation describing the competition of two
substrates for a single site on an enzyme. At high concentra-
tions of ATP, ATP occupies all specific binding sites. Thus,
the observed fluorescence intensity arises from nonspecific
binding of mantATP. Mant-nucleotides bound nonspecifi-
cally to the cell bundle account for 525 3% of the total fluo-
rescence in the absence of competition with ATP. This is
slightly higher than the 40% observed in skeletal psoas tissue
(10). The affinity of mantATP for myosin is 1.55 0.3 times
higher than that of ATP. This is similar to that observed in
skeletal fibers and in agreementwith solution studies showing
tighter binding ofmantATP tomyosin or actomyosin (10,13).
The slow component of fluorescence decay in a subse-
quent chase with ATP was also greatly reduced by additiondiac muscle
T1 (s) P2 T2 (s)
.01 145 1 0.275 0.01 1445 10
.03 125 1 0.295 0.02 1385 21
.01 105 1 0.095 0.01 2615 49
.02 95 1 0.045 0.02 755 16
.06 175 4 0.085 0.01 1235 12
.02 125 1 0.195 0.02 765 10
.04 265 2 0.265 0.02 2285 22
utions. The third column gives number of experiments averaged. P1 and P2
hases of the two-exponential function that was fit to the data (see Materials
or when the nucleotide in the chase was 250 mMmantADP, and these results
n with ATP.
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FIGURE 2 Comparison of three conditions is shown: 1), incubation in
250 mM mantATP chased by 4mM ATP (C); 2), incubation in 250 mM
mantATP chased by 4 mM ADP (B); and 3), incubation in 250 mM
mantADP chased by 4 mM ADP (6). All of the data were obtained from
the same muscle bundle. Parameters of the fits to the data shown here are
provided in the Supporting Material.
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FIGURE 3 Determination of the fraction of mant nucleotides bound
specifically to theATPbinding sites in both skeletalmuscle fibers (,,dashed
line) and cardiac cells (C, solid line). The cells were incubated in 250 mM
mantATP with varied concentrations of ATP. The fluorescence obtained was
normalized to the fluorescence in the absence of addedATP. The datawere fit
to a simple competition model. (Solid and dashed lines) Intensity ¼ INS þ
(1 INS)/([ATP]KappATP /[mATP]KappmATPþ 1), where INS is the inten-
sity due to nonspecific binding. This defines the fraction of mant-nucleotides
nonspecifically bound to the cell bundles, and the ratio of the apparent affin-
ities of the two nucleotides for the myosin binding site, Kapp. The equation
was derived assuming that both nucleotides are present in excess of their Km
values, which is true for the conditions used. The nonspecific fraction was
0.41 5 0.02 for skeletal fibers (data from Stewart et al. (10)) and
0.525 0.03 for cardiac cells. The ratio of the affinities of ATP andmantATP
was 0.565 0.07 for skeletal fibers and 0.675 0.18 for cardiac cells.
1972 Hooijman et al.of 4 mM ATP to the incubation (see Table 1). The observed
magnitude of the second component of the fit, P2 ¼ 0.08, is
only a little greater than that expected from the remaining
fraction of specifically bound nucleotides, 4%, under these
conditions. These results show that the component of nucle-
otides released slowly arises from the specifically bound
nucleotides. The absolute concentration of mant-nucleotides
bound to the muscle was determined as described previously
(10). The concentration of nucleotides bound specifically to
the fiber, 1445 7 mM (mean5 SE, n ¼ 10), was similar to
the concentration of myosin heads, 157 mM (18). Assuming
that all specific binding is due to mant-nucleotides bound to
myosin, the observed amplitude of the slow component,
0.28, indicates that 58% of the myosin heads in the relaxed
muscle are in the SRX.
The location of the fluorescence bound to the muscle was
determined by spinning disk confocal microscopy. Confocal
microscopy was used because the depth of field of the epi-
fluorescence microscope is short, making it difficult to
resolve individual sarcomeres in the image. Fig. 4 shows
that the fluorescence observed during the chase was found
largely in bright bands perpendicular to the axis of the
muscle. The width of the bright bands was 1.5 5 0.2 mm,
and did not vary as the sarcomere length varied from 2.2
to 3.5 mm. Their length and lack of change with sarcomere
length, show that these bands correspond to the sarcomeric
A-bands, which contain the myosin filaments. Thus, a large
fraction of the mant-nucleotides are bound to myosin during
the chase phase.
We conclude that an SRX exists in cardiac muscles that
has many similarities to the one previously identified in
skeletal muscle. In both muscle types, the release of fluores-Biophysical Journal 100(8) 1969–1976cence occurs with two components—one rapid, and one
with a time constant much longer than that of the normal
relaxed state. Avariety of experiments show that the fluores-
cence component with a long time-constant arises from
release of mant-nucleotides from myosin.Myosin turnover rates and the SRX in active
muscles
Despite the similarities between skeletal and cardiac
muscles, there were several experimental protocols in which
the cardiac results differed from the skeletal. These involved
situations in which a fraction of myosin heads were in the
SRX while adjacent myosin heads were strongly bound to
actin, either in active muscle or in rigor-ADP states. When
the muscle was initially relaxed in 250 mM mantATP and
chased with 4 mM ADP, a portion of the myosin heads
are initially in the SRX while other heads have bound
ADP and are forming rigor-ADP bonds with actin. In this
case a slow decay of fluorescence was observed, although
with reduced amplitude, 0.19 5 0.02, and time constant,
74 5 10 s. This observation is very different from that in
skeletal muscle where a chase with 4 mM ADP resulted in
virtual elimination of the slow component (10).
FIGURE 4 Bundle of cardiac cells visualized by spinning-disk confocal
microscopy after 1.5 min in the chase phase. The cells were incubated in
a solution containing 125 mM mantATP for 2 min then chased with a solu-
tion containing 4 mM ATP for 1.5 min before taking the image. The hori-
zontal stripes are ~1.5 mm in width, close to the length of the A-band in
cardiac muscles, showing that much of the fluorescence intensity remaining
in the muscle is associated with the A-band. The sarcomere length is 2.1
mm. The bar represents 10 mm.
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FIGURE 5 SRX is present in active cardiac muscle but not active skeletal
muscle. Muscles were relaxed in mantATP and were chased with either a re-
laxing solution containing 4mM ATP (red) or an activating solution con-
taining an additional 3 mM CaCl2 in the presence of 5 mM EGTA,
pCa ¼ 5.7 (blue). (A) In skeletal fibers, the fluorescence decays slowly in
a relaxing solution (upper curve), but quickly in an activating solution
(lower curve). This shows that in activated skeletal fibers the myosin heads
transition rapidly out of the SRX. (B) In cardiac muscles, the decay of fluo-
rescence is not changed between chase with relaxing and activating solu-
tions. This shows that myosin heads in the SRX remain in that state
when adjacent myosin heads are interacting with actin and generating force.
Parameters of the fits to the data shown here are provided in the Supporting
Material.
Cardiac Myosin with a Low Metabolic Rate 1973Thus, in cardiac tissue the release of nucleotides by
myosin heads in the super relaxed state is affected to a lesser
extent by rigor-ADP states of adjacent myosin heads than is
observed in skeletal fibers. In skeletal tissue, it was sug-
gested that myosin heads in the super relaxed state were de-
stabilized by the interaction of adjacent myosin heads with
actin to provide for a rapid recruitment of all myosin heads
in activated fibers; however, this hypothesis was not tested
directly (10).
This explanation was tested directly by measuring the
properties of the super relaxed state in partially activated
skeletal and cardiac muscles. Muscles were partially acti-
vated in 1.8 mM Ca2þ (pCa ¼ 5.7). The force generated in
this solution was 57 5 4% (mean 5 SE, n ¼ 15) of that
achieved by full activation for cardiac fibers, and was
56 5 3% (mean 5 SE, n ¼ 14) for skeletal fibers (see
Fig. S3). At full activation, the cardiac fibers generated
40 5 8 kN/m2, which is in line with other measurements
of maximal cardiac force when adjusted for the 45% inhibi-
tion of tension due to 5 mM phosphate in the experimental
buffer (19,20). Activation was rapid for cardiac fibers. The
time to half-activation depended on the diameter of the fiber,
but was ~45 1 s for fibers with a diameter of 80 mm, which
was the maximum used here. Thus, activation of the fibers
had been achieved well before measurement of the time
course of the SRX. Partial activation was used to minimize
artifacts due to muscle movements that complicated theanalysis of fully activated muscles. This caused minimal
movement ofmuscles that were held at both ends. In partially
activated skeletal fibers, the fluorescence intensity decayed
rapidly during the chase (see lower trace in Fig. 5 A).
This observation shows that myosin heads initially in the
SRX were rapidly (faster than the temporal resolution of our
experiments, ~20 s) recruited into states with a high nucle-
otide turnover rate. This experiment provides direct
evidence for the hypothesis put forward by Stewart et al.
(10) that cooperative interactions between myosin heads
in skeletal fibers would lead to full activation of the thickBiophysical Journal 100(8) 1969–1976
1974 Hooijman et al.filament. In dramatic contrast, in partially activated cardiac
muscles, the decay of fluorescence intensity was little
changed from that in a chase with a relaxing solution,
showing that myosin heads remain in the SRX during partial
activation (see Fig. 5 B). These observations demonstrate
a fundamental difference in the cooperativity between
myosin heads in super relaxed filaments from skeletal and
cardiac muscles, and, as discussed below, demonstrates
that this state plays different roles in the two types of
muscle.DISCUSSION
Our major new observation is that the state of myosin in
relaxed cardiac muscle is not the single monolith that had
been previously assumed. Instead there are two subpopula-
tions of relaxed cross-bridges (normal-relaxed and the SRX)
with ATP-turnover rates that differ by approximately a factor
of 5. The data indicate that the SRX in cardiac muscles has
many similarities to that previously identified in skeletal
muscle. In both muscle types, the release of fluorescence
in the basic experiment occurs with two components—one
rapid and compatible with nucleotide turnover by the
normal relaxed state, and one with a time constant much
longer than that of the relaxed state. The nucleotide turnover
time in the cardiac SRX, 138–144 s, is>5 times longer than
in the normal relaxed state, ~27 s (16). The fraction of the
total muscle fluorescence associated with the slow compo-
nent is similar in the two muscle types. The SRX only
occurs when muscles are relaxed in the initial incubation
phase. Thus, we conclude that an SRX occurs in both
skeletal and cardiac muscles.A structural hypothesis for the mechanism
of the inhibition of myosin ATPase activity
The fact that super-relaxed cross-bridges are seen only in
relaxed cell bundles and not in isolated myosin implies
the involvement of a structural component associated with
the filament array in the downregulation of the ATPase
rate for the SRX. Electron microscopy has identified a struc-
tural motif in which interacting myosin heads are helically
ordered along the backbone of the myosin thick filament
(21–23). In some types of muscles, in which activation is
controlled through myosin rather than the thin filament,
myosin heads in this structural motif release nucleotides
very slowly (24,25).
Of particular note, this same structural motif with reduced
ATPase has recently been identified in mammalian skeletal
myosin and cardiac thick filaments, leading to the hypoth-
esis that this motif is common to many muscle types
(26,27). Thus, we suggest that the inhibition of nucleotide
turnover by myosin heads in the SRX in cardiac muscles
is caused by binding of the myosin heads to the core of
the thick filament. A similar hypothesis for the inhibitionBiophysical Journal 100(8) 1969–1976of skeletal myosin ATPase activity has been proposed
(10). The ordered structure of the cardiac thick filament is
dynamic, and can be modulated by several known factors,
including phosphorylation of the myosin regulatory light
chain and myosin binding protein-C (28–30). Accepting
the structural hypothesis for inhibition of the myosin
ATPase activity, these factors would also affect the popula-
tion of the SRX.Why would incorporation of the myosin into an
array where they are bound to the core of the thick
filament provide such a large inhibition in ATP
turnover rate?
Inhibition of myosin ATP turnover by mechanical immobi-
lization has been shown to occur in myosin precipitates (31),
and in myosin immobilized on SiO2 surfaces (32). Myosin
in crystals is also incapable of nucleotide hydrolysis (33).
When bound to the core of the thick filament, myosin heads
are immobilized by multiple contacts with the core of the
filament and with adjacent heads. It is possible that preven-
tion of the large changes in conformation that occur during
the nucleotide cycle is inhibiting the cycle.Possible roles of the SRX in cardiac muscle
Themost significant difference between the cardiac and skel-
etal SRX states is that cross-bridges remain in the cardiac
SRX even under conditions of partial activation. This
contrasts with skeletal muscle where rapid recruitment of
force-generating cross-bridges is required for normal physi-
ological function. The rapid turnover of nucleotides
observed in skeletal fibers during chase with ADP or ATP
plus calcium (shown in Fig. 5 A) is attributed to cooperative
interactions between myosin heads in the thick filament.
Myosin heads that are interacting strongly with actin induce
adjacent heads in the SRX to transition out of that state and to
commence interacting with actin as well. This mechanism
provides for the ability of a skeletal fiber to achieve full
activation in a few milliseconds. A cooperative disordering
of the thick filament has been observed during the activation
of frog skeletal muscle fibers stretched to partial overlap (34).
During activation, all of the myosin heads rapidly leave their
binding sites on the core of the thick filament and become
disordered, although only half of them are overlapped by
the actin filaments. Myosin heads in the overlap region
must have acted cooperatively through the thick filament to
disorder heads that were not capable of interactingwith actin.
This cooperative interaction is much weaker or missing in
cardiac filaments. The nature of this cooperativity is a strong
determinant of the function of this state. In skeletal muscle,
the population of the SRX is appreciable only in relaxed
muscle, where it plays a role in determining the metabolic
rate. In cardiac cells, the SRX can provide an additional
modulatory mechanism on the active muscle, influencing
Cardiac Myosin with a Low Metabolic Rate 1975the recruitment of force-producing cross-bridges out of the
relaxed states to produce the more graded cardiac mechan-
ical output.
We note that an alternative possibility to explain the
apparent difference in cooperativity between skeletal and
cardiac muscle, is via changes in the thin filament. Addition
of high concentrations of ADP to resting skeletal or cardiac
muscle produces isometric tension via a cooperative activa-
tion of the thin filament (17). The Hill coefficient for skel-
etal muscle (coefficient of 3) shows slightly more
cooperativity than that for cardiac muscle (coefficient of
2). Thus, cooperative interactions occurring through the
thin filaments may also play a role.
Although the SRX has been proposed to play a role in
adaptive thermogenesis in skeletal muscle (10), modulation
of the population of the SRX to produce thermogenesis in
cardiac tissue is an unlikely function. Skeletal muscle may
be an optimal tissue for adaptive thermogenesis, because
of its low basal rate and its unique reserve metabolic
capacity. The continuous pumping activity of the heart
produces a large metabolic load on the cardiac tissue, and
any additional load to produce thermogenesis would be dele-
terious. Instead, we suggest that the SRX could play a role in
regulating the energy use of the cardiac muscle cell. By
sequestering a portion of the myosin heads into a state where
they do not interact with actin and they have a very low rate
of energy utilization, the SRX could provide a very energy
efficient mechanism of regulating myocardial output.
By effectively parking myosin heads on the thick filament
in the SRX, where they consume very little energy, the over-
all metabolic rate of the myocardium could be optimally
reduced. Unlike skeletal muscle, these heads would not be
recruited with each heart beat, but would remain in the
SRX as other heads generated force, as shown in Fig. 5 B.
This could play a significant role in regulating the energy
utilization of the myocardium during normal operation.
Supporting this concept are data showing that dephosphory-
lation of the myosin regulatory light chain, known to stabi-
lize the array of heads bound to the thick filament, decreases
output in living cardiac muscle (35,36). However, the SRX
would likely play a more major role in stressful conditions.
When exposed to stressful conditions the heart can induce
mechanisms to shut down energy-using processes early
during ischemia and in states that are cardioprotective,
known as myocardial hibernation or stunning (1,2,9,37).
Although considerable work has been done in identifying
factors that modulate basic cellular energy utilization, little
attention seems to have been paid to defining factors that
modulate the underlying, energy-intensive actomyosin
interaction as a cardioprotective mechanism.
Does the SRX play a role during the functioning of the normal
heart?
The data shown in Fig. 5 B demonstrate that the population
of the SRX is not changed by the presence of activation bycalcium. Thus, the SRX provides a mechanism for seques-
tering a portion of the myosin heads into a quiescent state.
The population of the SRX would not depend on the activa-
tion level of the cell but on other factors that affect the struc-
ture of the thick filament. In addition to providing
a mechanism exerting another level of control on force
generation, the SRX provides a mechanism that is more
energy-efficient than is the normal relaxed state.
How large is the difference between reducing the cardiac
output by sequestering myosin heads in the SRX relative
to leaving them in the normal relaxed state?
To calculate this difference, we assume that the activity of
myosin in the normal relaxed state is the same as that of
purified rabbit ventricular myosin, 0.037 s1. The enthalpy
released by ATP hydrolysis if all of the myosin heads were
in the normal relaxed state in rabbit cardiac muscle would be
~0.4 W/kg. The basal rate of the myocardium is quite vari-
able but has been measured in rabbit whole heart to be
2.3 W/kg (38). Thus, the ATPase of myosin in the relaxed
state would represent 17% of the total metabolism. If these
heads were sequestered into the SRX, most of this energy
utilization would be saved. Thus, shifting populations
between the normal relaxed state and the SRX could make
a small but still significant contribution to the energy utiliza-
tion of the resting heart.
The metabolic rate of the activated myocardium is of
course much higher and varies with the strength of the
contractile activity. The SRX will play a more prominent
role at lower levels of activity. The metabolic rate of rabbit
myocardium during isovolumic activations at one-quarter of
the maximum rate is ~10 W/kg (39,40). The metabolic rate
of normally relaxed myosin would amount to 4–8% of the
total metabolic rate of the functioning myocardium. Again,
if the relaxed heads were in the SRX this amount of energy
utilization could be saved. Thus, these calculations show
that the SRXcouldmake a small contribution to the efficiency
of the working myocardium. Although small, any increase
in cardiac efficiency is advantageous to the organism.SUMMARY
We identify what we believe to be a new state of myosin in
cardiac muscle with a very low ATP turnover rate. This state
could play a role in decreasing the metabolic load of the
myocardium. The mechanism proposed here for cardiac
muscle suggests that therapeutic interventions that increase
the population of the SRX would be cardioprotective during
times of stress. They may also be useful in preserving organs
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